SER earnings: a positive outcome, +14.8%

On March 30, 2020, Serina Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +14.8% in the window around the event. It had already run -29.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.